Screener
Agios Pharmaceuticals AGIO Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 82,403 | 104,111 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 125,000,000 shares authorized; 75,821,241 shares issued and 59,604,830 outstanding at June 30, 2026, and 74,665,003 shares issued and 58,448,592 outstanding at December 31, 2025 | 76 | 75 |
| Additional paid-in capital | 2,591,745 | 2,555,037 |
| Accumulated other comprehensive (loss) income | (1,795) | 2,193 |
| Accumulated deficit | (761,519) | (561,705) |
| Treasury stock, at cost (16,216,411 shares at June 30, 2026 and December 31, 2025) | (802,486) | (802,486) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's common stock shares issued?
- Agios Pharmaceuticals (AGIO) reported common stock shares issued of 75.8M in Q2 2026.
- How has Agios Pharmaceuticals's common stock shares issued changed year-over-year?
- Agios Pharmaceuticals's common stock shares issued increased by 2.1% year-over-year, from 74.3M to 75.8M.
- What is the long-term trend for Agios Pharmaceuticals's common stock shares issued?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's common stock shares issued has grown at a 1.5% compound annual growth rate (CAGR), from 69.3M to 74.7M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.
Ask your AI about Agios Pharmaceuticals's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude